Op-Ed: Mark Cuban won’t fix our drug pricing problem
LA TimesMark Cuban, the billionaire “Shark Tank” celebrity and Dallas Mavericks owner, is getting attention again — this time for his Mark Cuban Cost Plus Drug Co., which seeks to reduce prescription drug prices for Americans. These monopolies reflect intentional and longstanding government policies to incentivize research investments by rewarding drug developers with substantial profits for new drugs that improve health and extend lives. Formal cost-effectiveness analysis compares a drug’s cost — accounting for savings the drug can create elsewhere, such as by reducing expensive hospitalizations — to its benefits, including extended life expectancy and improved quality of life. Efforts such as the Mark Cuban Cost Plus Drug Co. can help bring cost relief to many Americans for generic medications they rely on.